showed that the oleuropein compound promotes the expression of XIST and the inhibition of miR194-5p/PD-L1 in TNBC, suggesting the feasibility of modulating the BC immunobiology by targeting lncRNAs and IC inhibitors (63). The gene discussed is XIST; the disease is breast cancer.